Title

B-Cell disorders and curcumin

RIS ID

107643

Publication Details

Golombick, T., Diamond, T. H., Manoharan, A. & Ramakrishna, R. (2017). B-Cell disorders and curcumin. Integrative Cancer Therapies, 16 (3), 255-257.

Abstract

Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.

Please refer to publisher version or contact your library.

Share

COinS
 

Link to publisher version (DOI)

http://dx.doi.org/10.1177/1534735415622013